What is Walvax Biotechnology Co Price-to-Operating-Cash-Flow?
As of today (2024-05-08), Walvax Biotechnology Co's share price is ¥15.12.
Walvax Biotechnology Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.54. Hence, Walvax Biotechnology Co's Price-to-Operating-Cash-Flow Ratio for today is 28.26.
The historical rank and industry rank for Walvax Biotechnology Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:300142'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 21.69 Med: 410.22 Max: 6810
Current: 28.32
During the past 13 years, Walvax Biotechnology Co's highest Price-to-Operating-Cash-Flow Ratio was 6810.00. The lowest was 21.69. And the median was 410.22.
Walvax Biotechnology Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥-0.05.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.54.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Walvax Biotechnology Co was -38.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 113.40% per year.
During the past 13 years, Walvax Biotechnology Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 165.50% per year. The lowest was -38.20% per year. And the median was 9.00% per year.
Walvax Biotechnology Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Walvax Biotechnology Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walvax Biotechnology Co Price-to-Operating-Cash-Flow Chart
|
Walvax Biotechnology Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
811.00 |
528.22 |
125.45 |
53.66 |
33.16 |
|
Walvax Biotechnology Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
39.42 |
35.50 |
32.11 |
33.16 |
28.75 |
Competitive Comparison of Walvax Biotechnology Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Walvax Biotechnology Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Walvax Biotechnology Co's Price-to-Operating-Cash-Flow falls into.
Walvax Biotechnology Co Price-to-Operating-Cash-Flow Calculation
Walvax Biotechnology Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 15.12 | / | 0.535 |
| = | 28.26 |
Walvax Biotechnology Co's Share Price of today is ¥15.12.
Walvax Biotechnology Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Walvax Biotechnology Co (SZSE:300142) Business Description
Traded in Other Exchanges
N/A
Address
Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Walvax Biotechnology Co (SZSE:300142) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300142 has been successfully added to your